Claesson-Welsh L - Search Results

1

Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies.

Claesson-Welsh L, Dejana E, McDonald DM. Claesson-Welsh L, et al. Trends Mol Med. 2021 Apr;27(4):314-331. doi: 10.1016/j.molmed.2020.11.006. Epub 2020 Dec 10. Trends Mol Med. 2021. PMID: 33309601 Free PMC article. Review.

2

VEGF-receptor signal transduction.

Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L. Cross MJ, et al. Trends Biochem Sci. 2003 Sep;28(9):488-94. doi: 10.1016/S0968-0004(03)00193-2. Trends Biochem Sci. 2003. PMID: 13678960 Review.

3

Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer.

Tugues S, Koch S, Gualandi L, Li X, Claesson-Welsh L. Tugues S, et al. Mol Aspects Med. 2011 Apr;32(2):88-111. doi: 10.1016/j.mam.2011.04.004. Epub 2011 May 6. Mol Aspects Med. 2011. PMID: 21565214 Review.

4

Signal transduction by vascular endothelial growth factor receptors.

Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Koch S, et al. Biochem J. 2011 Jul 15;437(2):169-83. doi: 10.1042/BJ20110301. Biochem J. 2011. PMID: 21711246 Review.

5

VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.

Sun Z, Li X, Massena S, Kutschera S, Padhan N, Gualandi L, Sundvold-Gjerstad V, Gustafsson K, Choy WW, Zang G, Quach M, Jansson L, Phillipson M, Abid MR, Spurkland A, Claesson-Welsh L. Sun Z, et al. J Exp Med. 2012 Jul 2;209(7):1363-77. doi: 10.1084/jem.20111343. Epub 2012 Jun 11. J Exp Med. 2012. PMID: 22689825 Free PMC article.

6

Signal transduction by vascular endothelial growth factor receptors.

Koch S, Claesson-Welsh L. Koch S, et al. Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006502. doi: 10.1101/cshperspect.a006502. Cold Spring Harb Perspect Med. 2012. PMID: 22762016 Free PMC article. Review.

7

VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation.

Hayashi M, Majumdar A, Li X, Adler J, Sun Z, Vertuani S, Hellberg C, Mellberg S, Koch S, Dimberg A, Koh GY, Dejana E, Belting HG, Affolter M, Thurston G, Holmgren L, Vestweber D, Claesson-Welsh L. Hayashi M, et al. Nat Commun. 2013;4:1672. doi: 10.1038/ncomms2683. Nat Commun. 2013. PMID: 23575676 Free PMC article.

8

Pulmonary lymphangiectasia resulting from vascular endothelial growth factor-C overexpression during a critical period.

Yao LC, Testini C, Tvorogov D, Anisimov A, Vargas SO, Baluk P, Pytowski B, Claesson-Welsh L, Alitalo K, McDonald DM. Yao LC, et al. Circ Res. 2014 Feb 28;114(5):806-22. doi: 10.1161/CIRCRESAHA.114.303119. Epub 2014 Jan 15. Circ Res. 2014. PMID: 24429550 Free PMC article.

9

Vascular permeability--the essentials.

Claesson-Welsh L. Claesson-Welsh L. Ups J Med Sci. 2015;120(3):135-43. doi: 10.3109/03009734.2015.1064501. Epub 2015 Jul 29. Ups J Med Sci. 2015. PMID: 26220421 Free PMC article. Review.

10

VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread.

Li X, Padhan N, Sjöström EO, Roche FP, Testini C, Honkura N, Sáinz-Jaspeado M, Gordon E, Bentley K, Philippides A, Tolmachev V, Dejana E, Stan RV, Vestweber D, Ballmer-Hofer K, Betsholtz C, Pietras K, Jansson L, Claesson-Welsh L. Li X, et al. Nat Commun. 2016 Mar 23;7:11017. doi: 10.1038/ncomms11017. Nat Commun. 2016. PMID: 27005951 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters